Thankful and glad Artelo Biosciences Inc (ARTL) final received the $4.2 million dollar Government grant needed for Stony Brook University to finish the development drug need to combine the fatty acid to the protein molecule to attack and destroy cancer. A huge milestone for Artelo Biosciences and Stony Brook University.
Will be following this development as it unfolds.
Will be following this development as it unfolds.
Recent ARTL News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/20/2026 04:15:18 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 08:30:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:00:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:06:33 PM
- Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 05/14/2026 08:05:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:00:32 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/04/2026 08:44:49 PM
- Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development • GlobeNewswire Inc. • 04/28/2026 12:25:00 PM
- Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile • GlobeNewswire Inc. • 04/20/2026 11:50:00 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/07/2026 08:18:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 12:00:10 PM
- Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements • GlobeNewswire Inc. • 04/07/2026 11:50:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/03/2026 08:46:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:35:26 PM
- Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/30/2026 08:46:00 PM
- Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/27/2026 02:40:00 PM
